| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1037152712 |
| P356 | DOI | 10.1038/SJ.ONC.1208093 |
| P8608 | Fatcat ID | release_ts5eciapbzg2fl4uh5ucgynj4e |
| P698 | PubMed publication ID | 15489897 |
| P5875 | ResearchGate publication ID | 8226749 |
| P2093 | author name string | Isa M Hussaini | |
| Patrick M Martin | |||
| Jae-Won Soh | |||
| Sean E Aeder | |||
| P2860 | cites work | Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cells | Q22254077 |
| Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR | Q28144113 | ||
| TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function | Q28204144 | ||
| Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin | Q28262178 | ||
| Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes | Q28307131 | ||
| FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse | Q28507537 | ||
| Stat3 as an oncogene | Q29614606 | ||
| Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism | Q29614737 | ||
| Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E | Q29618009 | ||
| The role of protein kinase C in cell surface signal transduction and tumour promotion | Q29618532 | ||
| The molecular heterogeneity of protein kinase C and its implications for cellular regulation | Q29619947 | ||
| Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin | Q29620399 | ||
| 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway | Q29620730 | ||
| Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells | Q33751730 | ||
| Cytoplasmic signaling pathways that regulate cardiac hypertrophy | Q34142151 | ||
| MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype | Q34212221 | ||
| Signaling pathways regulating gliomagenesis | Q35056649 | ||
| Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter | Q35787692 | ||
| Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. | Q37170896 | ||
| Bidirectional modulation of insulin action by amino acids | Q37380395 | ||
| Differential effects of overexpression of PKC alpha and PKC delta/epsilon on cellular E2F activity in late G1 phase | Q38357962 | ||
| Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C. | Q39575845 | ||
| Regulation of protein kinase C and role in cancer biology. | Q40504332 | ||
| Proliferation of human melanoma cells is under tight control of protein kinase C alpha | Q40565036 | ||
| ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1. | Q40666458 | ||
| The potential of protein kinase C as a target for anticancer treatment | Q40815216 | ||
| Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice | Q40881142 | ||
| Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal protein S6. | Q40960220 | ||
| Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells | Q40972355 | ||
| The role of protein kinase C alpha and epsilon isozymes in DNA synthesis induced by muscarinic receptors in a glial cell line | Q40991956 | ||
| Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells | Q41116723 | ||
| Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells | Q41743877 | ||
| Amino acid availability regulates p70 S6 kinase and multiple translation factors | Q41913722 | ||
| Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents | Q42371610 | ||
| PKCeta enhances cell cycle progression, the expression of G1 cyclins and p21 in MCF-7 cells | Q43800233 | ||
| Distinct effects of bFGF and PDGF on oligodendrocyte progenitor cells | Q44238794 | ||
| The inhibition of oligodendrocytic differentiation of O-2A progenitors caused by basic fibroblast growth factor is overridden by astrocytes | Q48287949 | ||
| Multiple routes to astrocytic differentiation in the CNS. | Q48455897 | ||
| PKCeta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes. | Q52585729 | ||
| CNTF and its receptor subunits in human gliomas. | Q55475931 | ||
| The role of integrin receptors in aspects of glioma invasion in vitro. | Q55476457 | ||
| Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. | Q55481185 | ||
| The protein kinase C isoforms leading to MAP-kinase activation in CHO cells | Q71695037 | ||
| P433 | issue | 56 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 9062-9069 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways | |
| P478 | volume | 23 |
| Q35000494 | A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancie |
| Q35606073 | A genome-wide approach to identify genetic loci with a signature of natural selection in the Irish population |
| Q79500818 | A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction |
| Q33384375 | A phase I trial of enzastaurin in patients with recurrent gliomas |
| Q37877409 | Anti-angiogenic therapy in glioma |
| Q40022074 | Antitumoral activity of rapamycin mediated through inhibition of HIF-1alpha and VEGF in hepatocellular carcinoma |
| Q41677353 | Co-ordinated activation of classical and novel PKC isoforms is required for PMA-induced mTORC1 activation |
| Q37313698 | Combination of enzastaurin and pemetrexed inhibits cell growth and induces apoptosis of chemoresistant ovarian cancer cells regulating extracellular signal-regulated kinase 1/2 phosphorylation |
| Q21261321 | Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma |
| Q39956127 | Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs |
| Q33388272 | Enzastaurin plus temozolomide with radiation therapy in glioblastoma multiforme: a phase I study |
| Q50100856 | Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies |
| Q34133089 | Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme |
| Q55462828 | Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance. |
| Q37191832 | Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading |
| Q35014198 | Frontier of epilepsy research - mTOR signaling pathway |
| Q38891606 | Ginsenoside Rh2 inhibits metastasis of glioblastoma multiforme through Akt-regulated MMP13. |
| Q39525805 | HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells. |
| Q36500396 | High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide era |
| Q30499055 | Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways |
| Q38441009 | Identification of proteins from formalin-fixed paraffin-embedded cells by LC-MS/MS. |
| Q40084736 | Involvement of protein kinase C in melatonin's oncostatic effect in C6 glioma cells. |
| Q39351494 | Nicotine and lipopolysaccharide stimulate the production of MMPs and prostaglandin E2 by hypoxia-inducible factor-1α up-regulation in human periodontal ligament cells. |
| Q38198095 | Novel therapies, including enzastaurin, in the treatment of ovarian cancer |
| Q30437051 | PKC eta as a therapeutic target in glioblastoma multiforme |
| Q38077454 | PKC signaling in glioblastoma. |
| Q39401591 | PKCη is a negative regulator of AKT inhibiting the IGF-I induced proliferation. |
| Q28543893 | PKCη/Rdx-driven phosphorylation of PDK1: a novel mechanism promoting cancer cell survival and permissiveness for parvovirus-induced lysis |
| Q54664674 | PRKCH gene polymorphism is associated with the risk of severe gastric atrophy. |
| Q37513179 | Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors |
| Q35570248 | Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma |
| Q30440938 | Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta |
| Q59072618 | Protein Kinase C (PKC) Isozymes and Cancer |
| Q28566892 | Protein kinase C alpha signaling inhibits cyclin D1 translation in intestinal epithelial cells |
| Q30440947 | Protein kinase C-alpha-mediated regulation of low-density lipoprotein receptor related protein and urokinase increases astrocytoma invasion |
| Q41613842 | Protein kinase C-θ inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway |
| Q42110411 | Protein kinase D2 is a novel regulator of glioblastoma growth and tumor formation. |
| Q24604987 | Protein kinases and phosphatases in the control of cell fate |
| Q36063003 | Retracted: miR-24-3p Suppresses Malignant Behavior of Lacrimal Adenoid Cystic Carcinoma by Targeting PRKCH to Regulate p53/p21 Pathway |
| Q37878907 | STATus and Context within the Mammalian Nervous System |
| Q37101028 | Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1 |
| Q39673159 | Significance of host cell kinases in herpes simplex virus type 1 egress and lamin-associated protein disassembly from the nuclear lamina |
| Q47112312 | Sphingosine 1-phosphate (S1P) signaling in glioblastoma multiforme-A systematic review. |
| Q37185828 | Src kinases in chondrosarcoma chemoresistance and migration: dasatinib sensitises to doxorubicin in TP53 mutant cells |
| Q52579980 | Targeting the protein kinase C family: are we there yet? |
| Q64243838 | The Enigmatic Protein Kinase C-eta |
| Q39984715 | The heat shock protein antagonist 17-AAG potentiates the activity of enzastaurin against malignant human glioma cells |
| Q38028872 | The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis |
| Q39986126 | The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines. |
| Q30442283 | The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway |
| Q39366432 | The transient receptor potential vanilloid-2 cation channel impairs glioblastoma stem-like cell proliferation and promotes differentiation |
| Q47150112 | mTOR Regulates Endocytosis and Nutrient Transport in Proximal Tubular Cells |
| Q36463349 | mTOR controls lysosome tubulation and antigen presentation in macrophages and dendritic cells |
Search more.